deListed Australia
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


ASX Announcements (courtesy of ASX)


ASX, Legal & CGT Status


(updated at weekends)
2007 2008 2009   ALL
Former (or subsequent) names


Shareholder links


Computershare Brisbane
Level 1, 200 Mary Street Brisbane QLD 4000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 7 3229 9860
RegistryWebsite RegistryEmail

Company details
Address: Level 2 , Brisbane Portal , 1 Breakfast Creek Road , NEWSTEAD , QLD, AUSTRALIA, 4006
Tel:  (07) 3250 1200 Fax: (07) 3250 1299

Date first listed: 09/10/2007

Activities: The Company is the successor entity to Peplin Limited ("Peplin") a former ASX-listed development stage pharmaceutical company which undertook a restructure by schemes of arrangement resulting in it becoming a wholly-owned subsidiary of the Company

delisted following completion of the merger with LEO Pharma A/S.


we understand that for each CDI held in respect of Peplin Shares as at 8 pm, 11 November 2009 (Brisbane time) the consideration was US$0.8495 in cash, without interest; and for every 20 CDIs held in respect of a Peplin Option as at the Record Date, an amount in cash, without interest, equal to the difference between the per share merger consideration of US$16.99 and the exercise price of the Peplin Options (A$16.80)


company announces that it has completed its merger with LEO Pharma A/S (LEO) after obtaining the approval of the majority of Peplin stockholders


we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - merge with LEO Pharma A/S - this corporate event may appear elsewhere in this company record


the securities of Peplin, Inc. (the "Company") will be suspended from quotation immediately, in accordance with the timetable for the proposed merger with LEO Pharma A/S (the "Merger"), following receipt of an announcement confirming that the Merger was approved at a special meeting of holders of common stock and CHESS Depositary Interests earlier today

View ASX Announcements (courtesy of ASX)


Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.


Company Updates
Post your comments here
Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)


    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    Tom WiggansChairman16/10/2007
    David SmithCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)

    Date of first appointment, title may have changed.